Neuroone Medical Technologies (NMTC) Free Cash Flow (2010 - 2026)
Neuroone Medical Technologies (NMTC) posted Free Cash Flow of -$1.4 million for Q1 2026, up 56.69% on a QoQ basis from -$3.2 million in Q4 2025, and down 2205.03% year-over-year from $64950.6 in Q1 2025.
Neuroone Medical Technologies (NMTC) Free Cash Flow (2010 - 2026) Analysis & Trends
Neuroone Medical Technologies' Free Cash Flow history runs 17 years deep, the most recent figure standing at -$1.4 million for Q1 2026.
- Quarterly Free Cash Flow fell 2205.03% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.6 million (down 52.73% YoY) and the FY2025 annual result came in at -$2.9 million, up 73.78% from the prior year.
- Free Cash Flow was -$1.4 million for Q1 2026 at Neuroone Medical Technologies, up from -$3.2 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $951635.0 in Q3 2022 and bottomed at -$3.8 million in Q4 2023.
- A 5-year average of -$2.2 million and a median of -$2.7 million in 2022 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow soared 146.1% — and 2026, when it tumbled 2205.03%.
- Neuroone Medical Technologies' Free Cash Flow stood at -$3.5 million in 2022, then fell by 9.78% to -$3.8 million in 2023, then surged by 104.77% to $183633.0 in 2024, then plunged by 1818.97% to -$3.2 million in 2025, then jumped by 56.69% to -$1.4 million in 2026.
- Business Quant data shows NMTC's Free Cash Flow at -$1.4 million in Q1 2026, -$3.2 million in Q4 2025, and -$1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neuroone Medical Technologies | 7.99 Mn | 5.19 Mn | 990,264.00 | -1.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.37 Mn |
| Mar 31, 2026 | -1.37 Mn |
| Dec 31, 2025 | -3.16 Mn |
| Dec 31, 2025 | -3.16 Mn |
| Sep 30, 2025 | -1.54 Mn |
| Sep 30, 2025 | -1.54 Mn |
| Jun 30, 2025 | -1.51 Mn |
| Jun 30, 2025 | -1.51 Mn |
| Mar 31, 2025 | -59,315.00 |
| Mar 31, 2025 | -59,315.00 |
| Dec 31, 2024 | 183,633.00 |
| Dec 31, 2024 | 183,633.00 |
| Sep 30, 2024 | -2.70 Mn |
| Sep 30, 2024 | -2.70 Mn |
| Jun 30, 2024 | -2.38 Mn |
| Jun 30, 2024 | -2.38 Mn |
| Mar 31, 2024 | -2.21 Mn |
| Mar 31, 2024 | -2.21 Mn |
| Dec 31, 2023 | -3.85 Mn |
| Dec 31, 2023 | -3.85 Mn |